¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Other specified injuries of lower limb, level unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • limb-girdle muscular dystrophy
    ÆÈ´Ù¸®ÀÌÀ½±Ù(À°)µð½ºÆ®·ÎÇÇ, Áö´ë±Ùµð½ºÆ®·ÎÇÇ
  • pelvic limb
    ´Ù¸®, ÇÏÁö
  • phantom limb
    ÇêÆÈ´Ù¸®, ȯ»ó»çÁö
  • phantom limb pain
    ÇêÆÈ´Ù¸®ÅëÁõ, ȯ»ó»çÁöÅëÁõ
  • phantom limb phenomenon
    ȯ»ó»çÁöÇö»ó, ÇêÆÈ´Ù¸®Çö»ó
  • phantom limb sensation
    ÇêÆÈ´Ù¸®°¨°¢, ȯ»ó»çÁö°¨°¢
  • standard limb lead
    Ç¥ÁØÆÈ´Ù¸®Àü±Ø, Ç¥ÁØ»çÁöÀü±Ø
  • unipolar limb lead
    ´Ü±Ø»çÁöÀ¯µµ, Ȭ±ØÆÈ´Ù¸®À¯µµ
  • upper limb
    ÆÈ, »óÁö
  • upper limb bud
    ÆÈ½Ï, »óÁö½Ï
  • upper limb prosthesis
    ÆÈº¸Á¶±â, »óÁöº¸Á¶±â
  • acceptable noise level
    Çã¿ë¼ÒÀ½¼öÁØ
  • antimicrobial level
    Ç×±Õ¼öÁØ
  • audiometric level
    û·Â¼öÁØ
  • air fluid level
    °ø±â¾×üÃþ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pelvic limb
    (¢¡lower limb) ´Ù¸®, ÇÏÁö
  • phantom limb
    ȯ»ó»çÁö, ȯ»óÆÈ´Ù¸®
  • standard limb lead
    Ç¥ÁØ»çÁöÀü±Ø
  • unipolar limb lead
    ´Ü±Ø»çÁöÀ¯µµ, Ȭ±ØÆÈ´Ù¸®À¯µµ
  • upper limb
    ÆÈ, »óÁö
  • phantom limb pain
    ȯÁöÅë, ȯ»óÆÈ´Ù¸®ÅëÁõ
  • phantom limb phenomenon
    ȯ»ó»çÁöÇö»ó
  • phantom limb sensation
    ȯÁö°¨, ȯ»óÆÈ´Ù¸®°¨°¢
  • upper limb prosthesis
    ÆÈº¸Á¶±â, »óÁöº¸Á¶±â
  • acceptable noise level
    Çã¿ë¼ÒÀ½¼öÁØ
  • air fluid level
    °ø±â¾×üÃþ
  • alertness level
    °¢¼º¼öÁØ
  • antimicrobial level
    Ç×±Õ¼öÁØ
  • audiometric level
    û·Â¼öÁØ
  • background level
    ¹è°æ¼öÁØ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • power level
    ÆÄ¿ì¾î·¹º§.
  • PLMS.see periodic limb movements during sleep
    ¼ö¸éÁß ÁÖ±âÀû »çÁö¿îµ¿
  • anterior limb of internal capsule
    ¼Ó¼¶À¯¸·¾Õ´Ù¸®
  • arteried of upper limb
    ÆÈµ¿¸Æ
  • artificial limb
    ÀÇÁö(ëùò¶), Àΰø »çÁö(ìÑÍïÞÌò·).
  • artificial limb
    ÀÇÁö(ëùò¶).
  • girdle of upper limb
    »ó(ß¾)Áö´ë.
  • girdle of upper limb
    »ó(ß¾)Áö ´ë.
  • hind limb
    µÞ´Ù¸®, ÈÄÁö(ý­ò¶).
  • inferior limb
    ÇÏÁö(ù»ò¶).
  • initial period of limb buds
    ÆÈ´Ù¸®½ÏÃʱâ
  • posterior limb of internal capsule
    ¼Ó¼¶À¯¸·µÚ´Ù¸®
  • primordium of upper limb bud
    ÆÈ½Ï¿ø±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • joints of lower limb girdle
    ÇÏÁö´ë¿¬°á(ù»ò¶ ÓáææÌ¿).
  • lower limb
    ÇÏÁö(ù»ò¶).
  • lower limb
    ´Ù¸®
  • lower limb
    ÇÏÁö(ù»ò¶).
  • lymph nodes of lower limb
    ´Ù¸®¸²ÇÁÀý
  • muscles of lower limb
    ´Ù¸®±ÙÀ°
  • primordium of lower limb bud
    ´Ù¸®½Ï¿ø±â
  • regiones membri inferioris =regions of lower limb ³ª
    ÇÏÁö, ÇÏÁöºÎ(ù» ò¶Ý»).
  • superficial veins of lower limb
    ¾èÀº´Ù¸®Á¤¸Æ
  • synovial sheaths of lower limb
    ´Ù¸®ÀÇ À±È°Áý
  • veins of lower limb
    ´Ù¸®Á¤¸Æ
  • veins of the lower limb
    ´Ù¸®Á¤¸Æ
  • lower digestive tract =lower gastrointestinal t.
    ÇϺμÒÈ­°ü(ù»Ý»á¼ûùη).
  • electrical injuries
    Àü±â ¼Õ»ó(ï³Ñ¨ áßß¿)
  • gun shot injuries
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Three parted limb
    ¼¼¸¶µð¿ø½ÃÆÈ´Ù¸®
    [¿¾ ¿ë¾î] »ïÀýÁö
  • Posterior limb of internal capsule
    ¼Ó¼¶À¯¸·µÚ´Ù¸®
    [¿¾ ¿ë¾î] ³»Æ÷Èİ¢
  • Anterior limb of internal capsule
    ¼Ó¼¶À¯¸·¾Õ´Ù¸®
    [¿¾ ¿ë¾î] ³»Æ÷Àü°¢
  • Caudal limb
    ¾Æ·¡°í¸®
    [¿¾ ¿ë¾î] ÇÏ°í¸®
  • Superficial vein of upper limb
    ¾èÀºÆÈÁ¤¸Æ
    [¿¾ ¿ë¾î] õ»óÁöÁ¤¸Æ
  • Cranial limb
    À§°í¸®
    [¿¾ ¿ë¾î] »ó°í¸®
  • Articulations of upper limb
    ÀÚÀ¯ÆÈ°üÀý
    [¿¾ ¿ë¾î] ÀÚÀ¯»óÁö°üÀý
  • Upper limb
    ÆÈ
    [¿¾ ¿ë¾î] »óÁö
  • Marginal veins of the limb
    ÆÈ´Ù¸®°¡ÀåÀÚ¸®Á¤¸Æ
    [¿¾ ¿ë¾î] »çÁöº¯¿¬Á¤¸Æ
  • Limb bud
    ÆÈ´Ù¸®½Ï
    [¿¾ ¿ë¾î] Áö·Ú
  • Initial period of limb buds
    ÆÈ´Ù¸®½ÏÃʱâ
    [¿¾ ¿ë¾î] Áö·ÚÇü¼ºÀü±â
  • Late period of limb buds
    ÆÈ´Ù¸®½ÏÈıâ
    [¿¾ ¿ë¾î] Áö·ÚÈıâ
  • ARTERIES OF UPPER LIMB
    ÆÈµ¿¸Æ
    [¿¾ ¿ë¾î] »óÁöµ¿¸Æ
  • Bursae of upper limb
    ÆÈÀÇ À±È°ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] »óÁö Ȱ¾×³¶
  • Synovial sheaths of upper limb
    ÆÈÀÇ À±È°Áý
    [¿¾ ¿ë¾î] »óÁö Ȱ¾×ÃÊ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sedimentation level
    ħÀüÃþ
  • window level
    â³ôÀÌ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LLL left lower [eye]lid; left liver lobe; left lower leg; left lower lobe
STANDOUT soft thresholding and depth cueing of unspecified techniques
URD unspecified respiratory disease; upper respiratory disease
AL absolute latency; acinar lumen; acute leukemia; adaptation level; albumin; alcoholism [and other dru...
RL radial line; radiation laboratory; reduction level; renal dysplasia-limb defects [syndrome]; resisti...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SCIs Spinal cord injuries
TBI Traumatic brain injuries
TBIs Traumatic brain injuries
SPF specified pathogen free
DRO Differential Reinforcement of Other Behaviour
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • joint of upper limb girdle
    »óÁö´ë ¿¬°á
  • limb kinetic apraxia
    Áö¿îµ¿¼º ½ÇÇàÁõ
  • phantom limb pain
    ȯ»óÁöÅë, ȯ°¢ÁöÅë, ȯÁöÅë
    1. Àý´ÜÇÏ¿© ¾ø¾îÁø »çÁö¿¡ ÀϾ´Ù°í »ý°¢ÇÏ´Â µ¿Åë. 2. ÀÌ¹Ì Àý´ÜÇØ¼­ »ó½ÇÇÑ ÆÈ´Ù¸®°¡ ¾ÆÁ÷ ÀÖ´Â °Íó·³ ´À³¢°í ±×°÷¿¡ ÅëÁõÀ» ´À³¢´Â °ÍÀ» ¸»ÇÑ´Ù. Àý´ÜÁöÀÇ ½Å°æ ¸»´ÜºÎ¿¡ ¼øÈ¯ Àå¾Ö³ª À¯Âø ¹ÝÈçÀÌ ÀÖÀ¸¸é »ý±â±â ½±´Ù. °ßµð±â ¾î·Á¿î ÀÛ¿­ÅëÀÌ ÀÖ°í Á¤½ÅÀûÀ¸·Î Æò¿ÂÇÑ »óÅ¿¡¼­´Â ÅëÁõµµ Àû´Ù.
  • superficial vein of upper limb
    ¾èÀº ÆÈ Á¤¸Æ
  • synovial sheaths of upper limb
    ÆÈÀÇ À±È°Áý
  • unipolar limb lead
    ´Ü±Ø »çÁö À¯µµ
  • upper limb
    »óÁö
    ÆÈ°ú ¼Õ.
  • acceptable noise level
    Çã¿ë ¼ÒÀ½
  • adaptation level
    ÀûÀÀ ¼öÁØ
  • anterior palate vault level
    Àü±¸°³Á¤ ³ôÀÌ
  • antimicrobial level
    Ç×±ÕÁ¦Ä¡
  • blood alcohol level
    Ç÷Áß ¾ËÄÚ¿Ã ³óµµ
  • blood oxygenation level dependant
    Ç÷Áß »ê¼ÒÄ¡ ÀÇÁ¸
  • c-AMP level
    ȯ½Ä AMP ·¹º§
  • carinal level
    ºÐ±â ´ë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
vasopressin level This test measures the amount of ADH in the serum. It is used to detect disorders that may affect the level of ADH in the serum. Normal values are: 0 to 4.7 pg/ml. Elevated ADH levels can indicate a CNS infection, fluid imbalance, CNS tumour, SIADH or acute porphyria. Low levels can indicate: diabetes insipidus or damage to the pituitary gland.
(27 Sep 1997)
maximum permissible exposure level The highest level of exposure to a substance, usually noxious, in the environment or during diagnostic and therapeutic procedures, that a body can tolerate without injury.
(12 Dec 1998)
mean sea level <marine biology> A tidal datum: the arithmetic mean of hourly water elevations observed over a specific 19-year cycle. Points on land can be referenced to a mean sea level, in which case the datum assumes zero elevation.
(09 Oct 1997)
gray level also gray value <microscopy> The brightness of pixels in a digitised video image, commonly expressed in integers ranging from 0 (black) to 255 (white) for an 8-bit digital signal.
(05 Aug 1998)
gray level histogram <microscopy> In digital image processing, a histogram that depicts the number of pixels at each gray value. The histogram can be used to measure the areas that have given ranges of gray values or to adjust image contrast by histogram stretching or equalisation.
See: Image histogram.
(05 Aug 1998)
Clark's level The level of invasion of primary malignant melanoma of the skin; limited to the epidermis, I; into the underlying papillary dermis, II; to the junction of the papillary and reticular dermis, III; into the reticular dermis, IV; into the subcutaneous fat, V. The prognosis is worse with each successive deeper level of invasion.
(05 Mar 2000)
cohb level A blood test which is performed on an arterial specimen and is a measurement of the amount of carbon monoxide which is present and bound to haemoglobin. This is an important test to diagnosis carbon monoxide toxicity (smoke inhalation). Normal carboxyhaemoglobin may be from 3% to as high as 12% in heavy smokers.
Symptoms of carbon monoxide poisoning begin at about 20% carboxyhaemoglobin.
(27 Sep 1997)
white level <microscopy> Also reference white level. The IEEE scale, or voltage level, of the video picture signal that corresponds to a specified maximum limit for white peaks.
(05 Aug 1998)
window level The CT number setting in Hounsfield units of the midpoint of the window width, which is the gray scale of the image; a typical window level for imaging the lungs if -500; for the abdomen, 0.
(05 Mar 2000)
hearing level The measure of the status of hearing as read directly on the hearing loss scale of an audiometer; described in decibels as a deviation from a standard value for zero on the audiometer.
(05 Mar 2000)
serum iron level A test that measures the amount of iron (Fe ++) in the blood. The test is performed when iron deficiency is suspected. Normal serum iron is 60 to 170 mcg/dl. Increased levels may be seen in the following: haemochromatosis, haemolysis, haemolytic anaemia, hepatitis, liver necrosis, haemosiderosis, iron poisoning and lead toxicity. Lower than normal levels are seen in chronic GI blood loss, iron deficiency anaemia, insufficient dietary iron, malabsorption, chronic heavy menstrual bleeding, nephrosis and late pregnancy.
(27 Sep 1997)
sound pressure level A measure of sound energy relative to 0.0002 dynes/cm2, expressed in decibels.
(05 Mar 2000)
substrate-level phosphorylation Synthesis of high-energy phosphate bonds through reaction of inorganic phosphate with an activated (usually) organic substrate.
(09 Oct 1997)
no-observed-adverse-effect level The highest dosage administered that does not produce toxic effects. The noael will depend on how closely dosages are spaced (lowest-observed-adverse-effect level and no-observed-effect level) and the number of animals examined. The ultimate objective is usually to determine not the "safe" dosage in laboratory animals but the "safe" dosage for humans. Therefore, the extrapolation most often required of toxicologists is from high-dosage studies in laboratory animals to low doses in humans. (casarett and doull's toxicology: the basic science of poisons, 4th ed)
(12 Dec 1998)
organic level The amount of organic matter prescribed to be left after logging.
(05 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • other
    ±×¹ÛÀÇ
  • some other time
    ¾ðÁ¨°¡ µý³¯¿¡(=some other day)
  • t'other
    ¶Ç Çϳª
  • A.N. Other
    ÀÍ¸í¾¾;¼±¼ö ¹ÌÁ¤
  • other
    µý;´Ù¸¥;´ÙÀ½ÀÇ;³ª¸ÓÁöÀÇ;every ~ Çϳª°É·¯;none ~ than ´Ù¸§ ¾Æ´Ñ;the ~ day(night)ÀÏÀü(¿äÀü³¯ ¹ã)¿¡;the ~ party »ó´ë¹æ;the ~ side (¹Ì±¹¿¡¼­ º») À¯·´;the ~ world ³»¼¼;Àú½Â
  • other
    ±×·¸Áö ¾Ê°í;µý ¹æ¹ýÀ¸·Î
  • other
    µý °Í(»ç¶÷);´Ù¸¥ Çϳª;³ª¸ÓÁö °Í;of all ~s ¸ðµç °Í(»ç¶÷)Áß¿¡¼­ ƯÈ÷;some ... or ~ ¹«¾ð(´©±º,¾îµò)°¡
  • level
    ÆòÆòÇÑ,¼öÆò,¼öÁØ,ÆòÆòÇÏ°Ô ÇÏ´Ù
  • A level
    »ó±ÞÇгâ½ÃÇè
  • O-level
    ±âÃÊÇз½ÃÇè
  • club floor(level)
    (È£ÅÚÀÇ)±Íºó¿ë Ç÷ξî;ȣȭ°´½ÇÇ÷ξî(º¸Åë È£ÅÚÀÇ ÃÖ»óÃþ)
  • constant-level balloon
    Á¤ °íµµ±â±¸
  • dumpy level
    ¸Á¿ø°æÀÌ ´Þ¸° ¼öÁرâ
  • fog level
    (Çö»óµÈ Çʸ§ÀÇ) ¹Ì³ëÃâ ³óµµ
  • level
    ¼öÆòÀÇ;ÆòÆòÇÑ;µ¿ÀÏ ¼öÁØÀÇ;¼­·Î ¿ì¿­ÀÌ ¾ø´Â;ÇѰᰰÀº;ºÐº°ÀÖ´Â;do one's ~ best Àü·ÂÀ» ´ÙÇÏ´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á